As seen on:
As seen on:
Latest Articles
How reinvesting dividends creates compounding growth, turns steady payouts into accelerating wealth, and why patient investors benefit most over time.
Unlock Asia’s next growth wave with these 3 healthcare stocks.
The government’s equity stimulus could reshape market sentiment, but its impact on dividends for retail investors deserves closer scrutiny.
Buried under all that market noise, this high-yield stock may offer steady income and upside.
The Smart Reads of the Year brings together the stories that defined 2025. From blue-chip compounding and CPF-beating dividends to REITs built for income and overlooked small caps with tailwinds, these were the ideas that mattered beyond market noise.
A quiet SGX holiday week saw a surprise REIT takeover bid, debt relief for Manulife US REIT, and NVIDIA’s largest-ever US$20 billion AI acquisition.
Popular
As DBS, SBS Transit and Sheng Siong reach new peaks, investors are asking: is it time to buy or take profits?
Looking to build a retirement portfolio? Focus on buying shares in companies that offer a combination of stability, income, and long-term growth.
Inflation eats into our money, but by understanding it better and investing wisely, we can fight it to grow our wealth.
Three Singapore REITs are first to the earnings dock, each offering different insight.
Stocks
When stocks hit multi-year highs, emotions often run ahead of fundamentals. How should investors think about valuation, momentum, and business quality at elevated prices?
The AI race is on as the cloud titans jostle for dominance. Who will win? Who will wilt? We check the leaderboard as they fight to stay ahead.
Look beyond blue chips to find three household-name small caps that provide the essential services Singapore relies on daily.
Three Singapore REITs, three stories, as FY2025 results reveal who is adapting and who is being tested in a higher-rate world.